White House indefinitely postpones Trump's speech on lowering drug prices

President Donald Trump has postponed this week’s speech on battling rising prescription drug costs, according to the White House. No future date, time or location has been announced for the speech, previously scheduled for Thursday, April 26.

Trump made high drug prices a major issue in his campaign for president, saying pharmaceutical companies are “getting away with murder” and has promised to tackle such rising costs.

The speech, despite some speculation it would be harsh on pharmaceutical companies, included relatively small steps in battling increased costs. Trump was expected to outline three major actions:

  • HHS will issue for a request for information on drug price policies.
  • CMS will alter its drug pricing dashboard, with the proposal being called a “shaming tool” by an Axios source.
  • The FDA will continue efforts on expanding the availability of generics.
""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup